))
Is a treatment in sight for MND?
Manage episode 470303056 series 3624055
Content provided by The Florey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Florey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Motor neurone disease was first described in the 1800s, but it’s only in the last two decades that researchers have been able to make serious inroads into understanding this fatal neurodegenerative disease.
Treatments remain very limited for patients and a cure is still some way off – but why is MND so challenging for patients, for their doctors and for researchers? Is there hope on the horizon?
In this episode, we tackle just that. Joining us is neurologist and Florey researcher, Dr Thanuja Dharmadasa, leader of The Florey’s MND research group, Professor Brad Turner, and Emma Vulin who was diagnosed with MND last year.
Emma is a Member of the Victorian Parliament and, despite her diagnosis, she continues to serve her electorate and attend to her official duties while juggling medical appointments and life as a mother of two.
Together with our host Dr Shane Huntington, our guests discuss the potential for personalised MND treatments and learn about world-first drug screening technology and MRI technology now in use at The Florey.
What would you like our neuroscientists to talk about? Email us at [email protected]
8 episodes
Share
